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Structural plasticity in the adult brain is essential
for adaptive behavior. We have found a remarkable
anatomical plasticity in the basal ganglia of adult
mice that is regulated by dopamine D2 receptors
(D2Rs). By modulating neuronal excitability, striatal
D2Rs bidirectionally control the density of direct
pathway collaterals in the globus pallidus that
bridge the direct pathway with the functionally
opposing indirect pathway. An increase in bridging
collaterals is associated with enhanced inhibition
of pallidal neurons in vivo and disrupted locomotor
activation after optogenetic stimulation of the
direct pathway. Chronic blockade with haloperidol,
an antipsychotic medication used to treat schizo-
phrenia, decreases the extent of bridging
collaterals and rescues the locomotor imbalance.
These findings identify a role for bridging collaterals
in regulating the concerted balance of striatal
output and may have important implications for un-
derstanding schizophrenia, a disease involving
excessive activation of striatal D2Rs that is treated
with D2R blockers.
INTRODUCTION
In the classical model of the basal ganglia circuitry, two parallel
and distinct neural circuits connecting the input nucleus to the
output nuclei have been described (Albin et al., 1989; Gerfen
and Surmeier, 2011; Kreitzer and Malenka, 2008; Valjent et al.,
2009). The direct (striatonigral) pathway is composed of
GABAergic medium spiny neurons (MSNs) that predominantly
express dopamine D1 receptors (D1Rs) and projects monosyn-
aptically from the striatum to the entopenduncular nucleus (EN)
and substantia nigra pars reticulata (SNr). In contrast, the indirect
(striatopallidal) pathway predominantly expresses D2 receptors(D2Rs) and projects from the striatum to the external segment
of the globus pallidus (GPe), which then relays to the EN and
SNr. These two pathways are thought to create a dynamic bal-
ance exerting opposing but coordinated actions on the control
of movement, cognition, and motivational processes (Cui et al.,
2013; Durieux et al., 2009; Ferguson et al., 2011; Hikida et al.,
2010; Hikosaka et al., 2000; Kravitz et al., 2010, 2012; Lobo
et al., 2010; Mink, 2003; Nambu, 2008; Tai et al., 2012). Accord-
ingly, an imbalance between both pathways has been postulated
for several brain disorders including obsessive-compulsive
disorder and Parkinson’s disease (Albin et al., 1989; Maia and
Frank, 2011).
The direct and indirect pathways are often described not only
as functionally opposing, but also as anatomically segregated.
However, this view has been challenged by single-cell tracing
studies in rats and monkeys (Fujiyama et al., 2011; Kawaguchi
et al., 1990; Le´vesque and Parent, 2005; Wu et al., 2000). In
the rat, of 120 striatal projection neurons that have been individ-
ually labeled in three independent publications (Fujiyama et al.,
2011; Kawaguchi et al., 1990; Wu et al., 2000), 37% projected
exclusively to the GPe (‘‘pure’’ indirect pathway), whereas only
3%projected only to the SNr or EN (‘‘pure’’ direct pathway). Sixty
percent of labeled neurons projected to the SNr/EN and
possessed collateral terminal fields in the GPe. Because these
GPe collaterals may have the ability to bridge the direct and
the indirect pathways, we refer to them here as ‘‘bridging’’ collat-
erals. Regulating the extent of bridging collaterals could be a
mechanism by which the direct pathway modulates the indirect
pathway, thereby affecting the behavioral balance maintained in
concert by both pathways.
Neuronal activity represents an important developmental
mechanism for regulating axonal projections and establishing
proper connectivity between different brain structures (Catalano
and Shatz, 1998; De Marco Garcı´a et al., 2011; Hua et al., 2005).
To determine whether similar mechanisms also occur in the
basal ganglia circuitry of the adult animal, we took advantage
of bacterial artificial chromosome (BAC) transgenic mice that ex-
press GFP under the control of the Drd1a or the Drd2 promoter
(Drd1a-GFP and Drd2-GFP mice; Gong et al., 2003). These
mice label the direct and the indirect pathways, respectively,Neuron 81, 153–164, January 8, 2014 ª2014 Elsevier Inc. 153
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tions of both pathways (Valjent et al., 2009).
Using a combination of transgenic mice and viral gene trans-
fer strategies, we found that the density of bridging collaterals
that connect the direct with the indirect pathway is regulated
by neuronal excitability in the adult brain. Specifically, we found
that increasing excitability of the indirect pathway is sufficient to
induce the growth of bridging collaterals. Chronic upregulation
of D2Rs (D2R-OE mice), which increases excitability of the indi-
rect pathway (Cazorla et al., 2012), similarly leads to a higher
density of bridging collaterals, a phenotype that is reversed
after viral-mediated decrease in excitability of D2R-OE MSNs.
In contrast, genetic D2R downregulation (Drd2/) or chronic
treatment with the D2R blocker haloperidol decreases the den-
sity of bridging collaterals. Increased bridging collaterals are
associated with enhanced inhibition of pallidal neurons in vivo
and disrupted motor activity after optogenetic stimulation
of the direct pathway. Strikingly, both the behavioral and
anatomical changes are reversed by chronic treatment with
haloperidol. These data show structural plasticity in the
adult basal ganglia that is regulated by chronic changes in
the dopamine system and is sensitive to antipsychotic medica-
tion. These findings may have important implications for
schizophrenia, in which D2R function is chronically increased
in the striatum and for which D2R blockade with antipsychotic
medication is still the most effective treatment (Howes et al.,
2012).
RESULTS
Striatopallidal MSN Excitability Regulates the Extent of
Striatonigral Bridging Collaterals
In analogy to what has been observed during development, we
reasoned that manipulating MSN excitability could lead to
axonal remodeling of the striatal output pathways in adulthood
(De Marco Garcı´a et al., 2011; Hua et al., 2005). To investigate
this hypothesis in the adult animal, we injected the dorsal stria-
tum with an adeno-associated virus (AAV) expressing the trans-
dominant negative Kir2.1AAA potassium channel (AAV-Kir2.1AAA)
using Drd1a-GFP and Drd2-GFP BAC transgenic mice to label,
respectively, the direct and indirect pathways (Gong et al.,
2003; Valjent et al., 2009; Figures 1A–1C). We previously showed
that this strategy efficiently increases MSN excitability by down-
regulating endogenous inward rectifying potassium (Kir) channel
function (Cazorla et al., 2012). Quantification ofDrd1a- andDrd2-
GFP-positive terminal fields in AAV-Kir2.1AAA mice revealed that
increasing MSN excitability did not affect the growth of the clas-
sical striatonigral and striatopallidal terminal fields (i.e., Drd1a-
GFP-positive terminals in SNr and Drd2-GFP-positive terminals
in GPe, respectively) but specifically promoted the growth
of striatonigral bridging collaterals in the GPe (Figures 1B
and 1C). The overall density of the presynaptic terminal marker
synaptophysin was increased in the GPe of AAV-Kir2.1AAA
mice and colocalized with Drd1a-GFP, confirming that Drd1a-
GFP-labeled terminals found in the GPe correspond to presyn-
aptic terminals and not to fibers of passage (Figures S1A and
S1B available online). Neuronal populations in the GPe have
been divided into parvalbumin-positive (PV-positive) and PV-154 Neuron 81, 153–164, January 8, 2014 ª2014 Elsevier Inc.negative cells (Mallet et al., 2012). Drd1a-GFP-labeled terminals
in the GPe of both controls and AAV-Kir2.1AAA mice were found
to contact both of these subpopulations (Figure S1C).
We then investigated whether the growth of bridging collat-
erals is regulated by neuronal excitability of the direct pathway
(Drd1a-MSN) and/or by excitability of the indirect pathway
(Drd2-MSN). AAVs expressing DIO-Kir2.1AAA for which expres-
sion is dependent on Cre recombinase (CRE) were injected
in the dorsal striatum of Drd1a-GFP;Drd2-CRE and Drd1a-
GFP;Drd1a-CRE mice. This strategy allowed the quantification
of Drd1a-GFP-labeled terminals after increasing MSN excit-
ability selectively in the direct or indirect pathway (Figures 1D–
1G). Strikingly, expression of Kir2.1AAA in the direct pathway
(Drd1a-CRE mice) had only a marginal effect on GPe collaterals,
and instead led to an increase in terminal density in the SNr
(Figure 1E). In contrast, expression of Kir2.1AAA in the indirect
pathway (Drd2-CRE mice) increased terminal fields of the direct
pathway in the GPe (Figure 1G). These findings show that
neuronal excitability of the indirect pathway is sufficient to pro-
mote the growth of GPe direct pathway bridging collaterals.
Interestingly, we observed that the increase in bridging collat-
erals was mainly restricted to the vicinity of Kir2.1AAA-infected
striatopallidal terminals (see ‘‘global’’ versus ‘‘local’’ effect in Fig-
ure 1G), in line with the topographical organization of striatopal-
lidal connections (Alexander et al., 1986).
D2Receptors Control theGrowth of Bridging Collaterals
via Their Regulation of MSN Excitability
What could be a physiological mechanism regulating excitability
of the indirect pathway? Indirect pathway MSNs express D2Rs
and are more excitable than direct pathway MSNs that express
D1R (Gertler et al., 2008). Moreover, chronic upregulation of D2R
in the striatum increases MSN excitability through the down-
regulation of Kir channels (Cazorla et al., 2012), while chronic
blockade of D2R using raclopride decreases excitability of the
indirect pathway (Chan et al., 2012). Based on these findings,
we hypothesized that chronic changes in D2R function could
regulate the extent of bridging collaterals via changes in excit-
ability of the indirect pathway. To test this idea, mice overex-
pressing striatal D2Rs (D2R-OE mice; Kellendonk et al., 2006)
and Drd2 knockout mice were crossed with BAC transgenic
Drd1a-GFP and Drd2-GFP mice (Figure 2).
Similar to what we observed in Kir2.1AAA mice, D2R-
OE;Drd1a-GFP mice showed a dramatic 1.75-fold increase in
GFP-positive terminal density in the GPe without affecting
the SNr (Figure 2A). The density of synaptophysin-positive
terminals was increased in the GPe and colocalized with
GFP-labeled terminals, indicating that the increase in GPe pre-
synaptic terminals arises from MSNs of the direct pathway
(Figures S2A and S2B). In addition, the distribution of terminals
contacting PV-positive and PV-negative neurons was not
changed in D2R-OEmice (Figure S2C). The increase in GPe ter-
minal fields was specific for the direct pathway as GFP-labeled
terminals emerging from the indirect pathway were not altered
in D2R-OE;Drd2-GFP mice (Figure 2B). Analysis of the medial
to lateral extent of bridging collaterals revealed that the highest
effect size is observed in the medial part of the GPe despite
an equal distribution of transgene expression in D2R-OE mice
Figure 1. Excitability of the Indirect
Pathway Regulates the Local Growth
of Direct Pathway Collaterals into the
Adult GPe
(A–C) Increasing MSN excitability promotes the
growth of striatonigral terminal fields in the GPe
of adult mice. (A) Sagittal sections showing
Kir2.1AAA-ires-HRGFP expression in the striatum.
Quantification of striatonigral (B) and striatopallidal
(C) terminal field density in adult mice expressing
the dominant negative Kir2.1AAA. ***p < 0.001,
compared to wild-type (WT); +p < 0.05, compared
to WT + AAV-ctl. Data are presented as mean ±
SEM (n = 4–6 mice/group). Scale bars, 1 mm.
Insets, 403 magnification (darkfield).
(D–G) Excitability of striatopallidal pathway is suf-
ficient to induce the growth of striatonigral bridging
collaterals into the GPe. Sagittal sections showing
expression of DIO-Kir2.1AAA-ires-mCherry (red)
and GFP (green) in Drd1a-GFP;Drd1a-CRE (D) and
inDrd1a-GFP;Drd2-CRE (F) mice. Scale bar, 1mm
(top panels), 50 mm (bottom). Global and local
quantification of striatonigral terminal density
in Drd1a-GFP;Drd1a-CRE (E) and in Drd1a-
GFP;Drd1a-CRE (G) + DIO-Kir2.1AAA mice. Global
effect was assessed by quantifying striatonigral
terminal density throughout the whole GPe. Local
effect was assessed by quantifying terminal den-
sity in GPe regions containing mCherry-labeled
terminal fields. *p < 0.05, **p < 0.01, ***p < 0.005,
compared to DIO-ctl. Data are presented as
mean ± SEM (n = 4–5 mice/group). Insets repre-
sent the striatal area expressing Kir2.1AAA-ires-
mCherry (orange). Note that the increase in
bridging collaterals is mainly restricted to the
vicinity of Kir2.1AAA-infected striatopallidal termi-
nals, in line with the topographical organization of
the striatopallidal connections (white arrows).
See also Figure S1.
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D2 Receptors Regulate Bridging Collaterals(Figure S2D). Associative corticostriatal loops therefore might
be more affected by the increase in bridging collaterals than
sensorimotor loops. To visualize individual collaterals in the
GPe further, low titer viruses (1.8 3 108 particles) were injected
into the striatum to infect only a sparse number of neurons. We
used AAV-DIO-Channelrhodopsin2 (ChR2) fused to enhanced
yellow fluorescent protein (eYFP) as a tracer in combination
with Drd1a-CRE mice to restrict the expression of ChR2-
eYFP to the direct pathway. D2R-OE mice show an increase
in the arborization of individual collaterals (Figure S2E). Quanti-
fication revealed that the number of higher order branches was
increased in D2R-OE mice, whereas the number of primary
branches emerging from passing axons was unaltered (Fig-
ure S2F). Conversely, in D2R heterozygous (Drd2+/;Drd1a-
GFP) and homozygous (Drd2/;Drd1a-GFP) knockout mice,
we found a gene-dose-dependent decrease in GFP-positive
terminal fields in the GPe (Figure 2C). GPe terminal fields
from the indirect pathway were not altered in D2R-OE andNeuron 81, 153–16knockdown mice (Figure 2D). Remark-
ably, restoring Kir function in D2R-OE
mice by injecting D2R-OE;Drd1a-GFPmice with an AAV expressing wild-type Kir2.1 (AAV-Kir2.1WT)
reversed the morphological phenotype (Figure 2E), confirming
that D2Rs regulate the extent of bridging collaterals via its
effect on neuronal excitability.
Bridging Collaterals Are Dynamically Regulated in the
Adult Brain and Are Sensitive to Chronic Administration
of Haloperidol
Because this reversal demonstrates structural plasticity in the
adult brain, we questioned whether dynamic changes in D2R
expression could affect the bridging collaterals in adulthood. In
D2R-OE mice, D2R overexpression can be switched off during
adulthood with doxycycline (Kellendonk et al., 2006). Adult
D2R-OE;Drd1a-GFP mice were fed doxycycline-supplemented
food for 3, 7, 14, and 60 days to turn transgenic D2R expression
off, and the density of GPe Drd1a-GFP-labeled terminal fields
was measured (Figure 3A). We found that the increased GPe
collateral terminal fields progressively reversed to almost control4, January 8, 2014 ª2014 Elsevier Inc. 155
Figure 2. D2 Receptors Bidirectionally Control the Extent of Bridging Collaterals by Regulating MSN Excitability
(A–D) GPe striatonigral bridging terminals are increased with D2R gain-of-function (D2R-OE mice) and decreased with D2R loss-of-function (Drd2/ mice).
Sagittal sections and terminal density quantification of striatonigral (A) and striatopallidal (B) pathways in control andD2R-OEmice. Sagittal sections and terminal
density quantification of striatonigral (C) and striatopallidal (D) pathways in Drd2+/+ and Drd2/ mice. *p < 0.05, **p < 0.01, ***p < 0.005, compared to controls;
#p < 0.05, Drd2+/ versus Drd2/. Data are presented as mean ± SEM (n = 4–6 mice/group). Insets, 403 magnification, darkfield (A) and brightfield (C).
(E) Increased bridging terminal density is restored in D2R-OE mice after striatal expression of AAV-Kir2.1WT-ires-HRGFP. *p < 0.05, ***p < 0.005, compared to
Ctl+AAV-ctl; ##p < 0.01, ###p < 0.005, compared to D2R-OE+AAV-ctl. Data are presented as mean ± SEM (n = 4–6 mice/group).
Scale bars, 1 mm. See also Figure S2.
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D2 Receptors Regulate Bridging Collateralslevels within 2 weeks of doxycycline treatment (Figures 3A, 3B,
S3A, and S3B). Most importantly, switching off expression in
the adult for 2 weeks followed by reinitiation of D2R overexpres-
sion (2 month doxycycline withdrawal) led to regrowth of axonal
terminal fields to nearly original levels, showing a high degree of
structural plasticity of bridging collaterals in adulthood that is
sensitive to D2R levels.
Because the density of bridging collaterals can be modulated
in the adult by manipulating D2R expression, we asked whether
the bridging collaterals are also sensitive to pharmacological
manipulation of D2R function using chronic treatment of halo-
peridol, a D2R blocker that is commonly used as antipsychotic156 Neuron 81, 153–164, January 8, 2014 ª2014 Elsevier Inc.medication in humans. After 2 weeks of haloperidol treatment
(1 mg/kg/day), bridging collaterals were decreased in both
D2R-OE and wild-type mice without affecting the classical
direct and indirect pathway terminals within the SNr and GPe,
respectively (Figure 3C). The reduction in the density of collat-
erals was of similar magnitude in D2R-OE mice treated for
2 weeks with either haloperidol or doxycycline (haloperidol,
72.3%; doxycycline, 75.6%; Figures 3B and 3C). To use
a different quantitative method independent of the GFP trans-
gene, we performed western blots using the presynaptic
markers synaptophysin and synaptosomal-associated protein
25. Protein levels were increased in the GPe but not the striatum
Figure 3. Bridging Collaterals Are Highly Plastic in the Adult Animal
and Are Sensitive to Haloperidol
(A) Transgenic D2R mRNA expression (upper row; in situ hybridization; scale
bar, 500 mm) is switched off in adult D2R-OE mice by doxycycline application
(Dox on). Expression is re-established after removal of doxycycline (Dox on
then off). Increased striatonigral GPe collaterals (bottom row; Drd1a-GFP
immunostaining; scale bar, 100 mm) are reversed to normal after switching
transgene expression off (Dox on). Collaterals grow back after re-expressing
the transgene (Dox on then off).
(B) Kinetics of collaterals retraction in the GPe of D2R-OE mice treated with
doxycycline for increasing time periods and regrowth after re-expressing the
transgene for 60 days (14 on + 60 off). Values are normalized to control mice
and are presented as mean ± SEM (n = 5–6 mice/group).
(C) Reduction of striatonigral but not striatopallidal terminals in the GPe of
control and D2R-OE mice treated for 14 days with haloperidol (1 mg/kg/day).
*p < 0.05, **p < 0.01, ***p < 0.005, compared to control; ##p < 0.01, compared
to D2R-OE. Data are presented as mean ± SEM (n = 8–9 mice/group).
See also Figure S3.
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reversed after switching off the transgene using doxycycline
(Figures S3C and S3D).Increased Bridging Collaterals Are Associated with
Increased Inhibition of GPe Cells after Optogenetic
Stimulation of the Direct Pathway In Vivo
Since MSNs are GABAergic, we investigated whether the direct
pathway—like the indirect pathway—has the ability to inhibit
GPe neurons via its bridging collaterals. Using optogenetics in
anesthetized mice, we stimulated the direct and indirect path-
ways selectively while recording from GPe neurons. Drd1a-
CRE and Drd2-CRE mice injected with AAV-DIO-ChR2 into the
dorsal striatum (Figure 4A) were implanted into the injection
site with an optic fiber connected to a laser source while a
recording electrode was lowered into the GPe (Figure 4B). As
expected, laser stimulation of indirect pathway MSNs (Drd2-
CRE mice) led to massive inhibition of the majority of GPe cells,
whereas control mice not injected with AAV-DIO-ChR2 (‘‘No
ChR2’’) remained unaffected by laser stimulation (Figure 4C).
Laser stimulation of direct pathway striatal neurons (Drd1a-
CRE mice) also led to an inhibition of basal firing rate of GPe
cells, which was smaller than in Drd2-CRE mice but enlarged
in Drd1a-CRE;D2R-OE mice (Figure 4C). Because the basal
firing rate of GPe neurons is about 10 Hz, we used 100 ms bins
to sample the responses. The latency of inhibition was compara-
ble among Drd1a-CRE;control, Drd1a-CRE;D2R-OE, and Drd2-
CRE mice, occurring for most activity recorded within the first
100 ms (Figure 4D). Because the indirect pathway (Drd2-CRE
mice) is an established monosynaptic pathway, the data are
consistent with a functional monosynaptic inhibition emerging
also from the direct pathway. Figure 4E shows a comparison
of relative spike numbers among the four groups.
To quantify the degree of inhibition, we used Z score analysis
(Figure 4F). The three experimental groups, Drd1a-CRE, Drd1a-
CRE;D2R-OE, and Drd2-CRE mice, differed significantly from
the non-ChR2 transfected control group (one-way ANOVA
[F(3,242) = 14.494; p < 0.001], Scheffe corrected post hoc com-
parisons, p < 0.05) and from each other [F(2,212) = 6.950, p <
0.01] (Figure 4F). Pair-wise comparisons of the Z scores revealed
that optical stimulation of striatopallidal neurons in Drd2-CRE
mice wasmore effective than stimulation of striatonigral neurons
at inhibiting GPe neurons in Drd1a-CRE mice. Similarly,
Drd1a-CRE;D2R-OE mice (M = 3.7118, SEM = 0.49125)
showed significantly more inhibition than Drd1a-CRE mice
(M = 1.9028, SEM = 0.29643), while not differing from Drd2-
CRE mice (M = 3.6796, SEM = 0.39120).
Based onZ score analysis, we found the proportion of inhibited
GPe neurons to be 68.4% in Drd2-CRE, 39.0% in Drd1a-CRE,
and 62.9% in Drd1a-CRE;D2R-OE mice (Figures 4G and 4H). A
Pearson chi-square test revealed a higher proportion of inhibited
cells in Drd1a-CRE;D2R-OE mice than in Drd1a-CRE mice (p <
0.01), with no significant differences compared to Drd2-CRE
mice. Inhibited units showed 55%, 71%, and 90% reduction in
activity compared to their prestimulation values in Drd1a-CRE,
Drd1a-CRE;D2R-OE, and Drd2-CRE mice, respectively (Fig-
ure 4I). The degree of inhibition differed between all three groups
[F(2,116) = 38.086, p < 0.01]. Basal firing rates were not affected
by the D2R transgene, but Drd2-CRE mice showed lower basal
firing rates than control Drd1a-CRE ‘‘No ChR2’’ mice (Drd1a-
CRE ‘‘No ChR2’’ mice: 13.3 ± 1.8 Hz; Drd1a-CRE + ChR2:
10.8 ± 1.0 Hz; Drd1a-CRE;D2R-OE + ChR2: 13.1 ± 1.1 Hz;Neuron 81, 153–164, January 8, 2014 ª2014 Elsevier Inc. 157
(legend on next page)
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Figure 5. Increased Bridging Collaterals
Are Associated with Disrupted Behavioral
Activation of the Direct Pathway
Behavioral activation after direct pathway stimu-
lation is disrupted in AAV-Kir2.1AAA-injected mice.
(A andC) Traces show locomotor activity ofDrd1a-
CRE;DIO-ChR2 (A) or Drd2-CRE;DIO-ChR2 (C) +
AAV-ctl or +AAV-Kir2.1AAA mice during open
field performance. Note that AAV-ctl and AAV-
Kir2.1AAA are CRE independent and are expressed
in both pathways. Data are mean only. Gray boxes
represent SEM of basal locomotion measured
during the pre- and postillumination phases.
(B and D) Summary of locomotor activity during a
30 s session measured in (A) and (C), respectively.
#p < 0.05, ##p < 0.001, repeated two-way ANOVA.
*p < 0.05, ***p < 0.001 compared to laser. Data are
presented as mean ± SEM (n = 5 mice/group). A
significant interaction between Kir2.1AAA and laser
illumination was observed in the direct pathway
(B), p < 0.001, but not in the indirect pathway (D).
See also Figure S4.
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D2 Receptors Regulate Bridging CollateralsDrd2-CRE + ChR2: 7.5 ± 0.6 Hz; one-way ANOVA, [F(3,242) =
7.560, p < 0.01], post hoc Scheffe corrected p < 0.05 for com-
parison between Drd1a-CRE ‘‘No ChR2’’ and Drd2-CRE mice).
This in vivo analysis of GPe firing is consistent with fast inhibition
by direct pathway collaterals. It further suggests that increased
density of bridging collaterals in D2R-OE mice strengthens
inhibitory modulation of the GPe, a major node of the indirect
pathway.
Changes in Bridging Collaterals Are Associated with
DisruptedMotor Behavior after Stimulation of the Direct
Pathway
Could increased inhibition in the GPe affect the behavioral bal-
ance of the direct and indirect pathways? Recently, Kravitz
et al. (2010) have shown that in vivo stimulation of the direct
pathway increases locomotion while stimulation of the indirect
pathway inhibits locomotion. Nevertheless, under nonstimulatedFigure 4. Increased Striatonigral Bridging Collaterals Are Associated w
(A and B) Set-up for the selective optogenetic activation of direct or indirect path
(A) Example of CRE-positive Drd1a- and Drd2-MSNs (red) expressing ChR2-YFP
(B) Schematic depicting fiberoptic implantation in the dorsomedial striatum and
(C–I) Optogenetic activation of the direct pathway reveals inhibition in the GPe th
(C) Peristimulus time histograms (PSTHs) showing the mean spike frequency o
(100 ms bins). Mice were injected with a control virus (No Chr2) or with a DIO-Ch
(D) Zoom-in of PSTH in (C) showing the latency of response 1,000 ms before and
stimulation.
(E) Summary graphs of relative firing frequency showed in (C) for direct compari
(F) Change in firing rate during laser-induced stimulation of direct or indirect p
**p < 0.01; n.s, not significant. All experimental groups differ from the control ‘‘N
(G) Proportion of GPe cell units for which basal firing rate is significantly decrease
differ from the control group (p < 0.001).
(H) Distribution of GPe cell response after laser-induced activation of direct or indi
to define cells that are significantly inhibited after laser stimulation.
(I) Degree of inhibition of GPe cells after laser-induced activation of direct and indi
(p < 0.001). Data are presented asmean ± SEM (no Chr2 injected: n = 3mice, 33 n
mice, 63 neurons; Drd2-CRE;control: n = 6 mice, 78 neurons).conditions, initiation of movements requires the concurrent and
coordinated activation of both pathways (Cui et al., 2013).
Here, we hypothesize that the increased inhibition of the GPe
associated with the increase in bridging collaterals should
affect behavioral activation after direct pathway stimulation
and thereby change the coordinated balance of the pathways.
We first analyzed locomotor activity in mice coinjected with
AAV-DIO-ChR2 and the nonconditional AAV-Kir2.1AAA that leads
to an increase in bridging collaterals without affecting the clas-
sical terminal fields (Figure 1B). Coinjection with a control virus
led to increased locomotor activity after direct pathway stimula-
tion (Figures 5A and 5B) and decreased locomotor activity after
stimulation of the indirect pathway (Figures 5C and D), as previ-
ously described (Kravitz et al., 2010). This effect was specific to
laser stimulation as the general motor activity of themicewas not
affected during habituation (Figures S4A–S4F) or when the laser
was switched off. Mice injected with DIO-ChR2 that do notith Enhanced GPe Inhibition
ways and concurrent recording of GPe cells in vivo.
(green) in the dorsomedial striatum. Scale bars, 20 mm.
positioning of the recording electrode in the GPe.
at is enhanced in D2R-OE mice.
f all recorded GPe neurons before, during, and after the 5 s laser stimulation
R2 virus for Drd1a-CRE;control, Drd1a-CRE;D2R-OE, and Drd2-Cre mice.
after laser illumination. Arrows indicate the first 100 ms bin recorded after laser
son of the four groups before, during, and after the 5 s laser illumination.
athway expressed as a Z score of the prestimulation firing rate distribution.
o Chr2 group’’ (p < 0.001).
d after laser stimulation. **p < 0.01; n.s, not significant. All experimental groups
rect pathway (1 bin Z scores). A cutoff was determined at2 (two negative SDs)
rect pathways. **p < 0.01. All experimental groups differ from the control group
eurons;Drd1a-CRE;control: n = 5mice, 72 neurons; Drd1a-CRE;D2R-OE: n = 5
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Figure 6. Disrupted Behavioral Activation of
the Direct Pathway in D2R-OE Mice Is
Rescued by Haloperidol
(A and B) Laser stimulation of the direct pathway
induces motor inhibition in D2R-OE mice and is
rescued after chronic treatment with haloperidol.
Data are mean only. Gray boxes represent SEM of
basal locomotion measured during the pre- and
postillumination phases.
(A) Traces show laser-induced locomotor activity
of Drd1a-CRE;DIO-ChR2;control and Drd1a-
CRE;DIO-ChR2;D2R-OE mice treated with either
saline or haloperidol (1 mg/kg/day) for 2 weeks.
(B) Summary of locomotor activity during a 30 s
session measured in (A). ###p < 0.0001, repeated
two-way ANOVA; ***p < 0.0001 compared to laser.
Data are presented as mean ± SEM (n = 6–8 mice/
group). A significant interaction between D2R
manipulation (D2R-OE and/or haloperidol) and
laser illumination was observed (p < 0.0001).
Chronic haloperidol has no effect on behavioral
inhibition after indirect pathway activation (see
Figure S5).
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fected by laser stimulation (Figures S4G and S4H). We then
testedmicewith increased collateral density in theGPe. Coinjec-
tion with AAV-Kir2.1AAA led to a decrease in locomotor activity
after stimulating the direct pathway (p = 0.005; laser/control
versus laser/Kir2.1AAA; Figures 5A and 5B), while inhibition of lo-
comotor activity after stimulating the indirect pathway remained
unchanged (Figures 5C and 5D).
Because D2 receptor upregulation increases bridging collat-
erals, an effect that is rescued by haloperidol, we also assessed
direct-pathway-dependent locomotor activation in D2R-OE
mice treated with chronic haloperidol. Drd1a-CRE mice crossed
with D2R-OE mice were injected with AAV-DIO-ChR2 into the
dorsal striatum and were then treated with either saline or halo-
peridol (1 mg/kg/day) for 2 weeks before analysis of motor
behaviors (Figures 6 and S5). As observed in the Kir2.1AAA exper-
iment, direct pathway stimulation increased locomotor activity
in Drd1a-CRE;control mice but decreased locomotor activity
in Drd1a-CRE;D2R-OE mice (p = 0.001; laser/control versus
laser/D2R-OE). The effect size was larger in D2R-OE mice than
in AAV-Kir2.1AAA-injected mice, probably due to the fact that
the expression area of Kir2.1AAA is restricted to the injection sites,
whereas D2R are upregulated in the entire striatum of D2R-OE
mice (Kellendonk et al., 2006). Basal (unstimulated) locomotor
activity was not altered in D2R-OE mice (Figures 6 and S5).
We also tested the effects of chronic haloperidol treatment
(2 weeks, 1 mg/kg/day) on direct-pathway-dependent locomo-
tion. Laser stimulation of the direct pathway in Drd1a-CRE;con-
trol mice treated with haloperidol efficiently induced locomotion
to levels of saline-treated mice despite decreased baseline
activity (p = 0.001; pre-/postcontrol + saline versus pre-/
postcontrol + haloperidol; Figures 6 and S5). Remarkably,160 Neuron 81, 153–164, January 8, 2014 ª2014 Elsevier Inc.chronic treatment with haloperidol
reversed the locomotor phenotype
observed in D2R-OE mice to the level ofcontrol mice. This reversal was also observed using a same-sub-
ject longitudinal design in a subgroup of mice that was tested
before and after chronic haloperidol treatment (Figure S5E).
Chronic haloperidol treatment had no effect on motor activity af-
ter stimulation of the indirect pathway in Drd2-CRE mice (Fig-
ures S5F and S5G), despite the fact that the indirect pathway
predominantly expresses D2Rs.
DISCUSSION
Neuronal activity has been found to be important during devel-
opment for regulating axonal projections and establishing proper
connectivity between different brain regions (Catalano and
Shatz, 1998; De Marco Garcı´a et al., 2011; Hua et al., 2005).
De Marco Garcı´a et al. (2011) have recently shown that, during
embryonic development, decreasing excitability via overexpres-
sion of Kir channels impairs proper axonal path finding of cortical
interneurons. In the adult animal, decreasing excitability of olfac-
tory sensory neurons via Kir overexpression also disrupts the
formation of a proper olfactory map (Yu et al., 2004). However,
olfactory sensory neurons regenerate throughout adulthood
and the olfactory system is known for its high degree of plasticity.
Here, using Kir-expressing viruses, we show that manipulating
excitability in the adult brain alters axonal terminal fields in the
basal ganglia, a structure that is a priori not known for its struc-
tural plasticity. In contrast to what has been observed during
development and the olfactory system, structural plasticity of
bridging collaterals is not cell autonomous since collaterals of
direct pathway grow after increasing excitability of indirect
pathway neurons.
It is currently unclear why this anatomical reorganization is
specific for the bridging collaterals of the direct pathway and
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indirect pathways. We believe that this is related to the non-
cell-autonomous nature of the mechanism. Altered activity of
the indirect pathway may lead to the release of growth factors
within the GPe (by indirect pathway terminals or GPe target
neurons) that are specifically recognized by direct pathway
bridging collaterals. This is particularly exemplified by the locally
restricted growth of bridging collaterals that remain in the vicinity
of AAV-DIO-Kir2.1AAA-infected striatopallidal projections.
What are the potential physiological mechanisms involved in
this anatomical rearrangement? Since neuronal excitability of
indirect pathway neurons seemed to be critical for the growth
of direct pathway collaterals, we focused on regulatory mecha-
nisms specific to this neuronal population. Striatopallidal
neurons of the indirect pathway predominantly express D2
receptors. Chronic D2R overexpression increases excitability
of the indirect pathway via downregulation of Kir channels,
whereas chronic blockade of D2Rs with raclopride decreases
striatopallidal excitability (Cazorla et al., 2012; Chan et al.,
2012). Changes in excitability of indirect pathway neurons
through regulation of Kir potassium conductances or by chronic
blockade of dopamine D2 receptors revealed plasticity in
bridging collaterals into the GPe. Surprisingly, this anatomical
rearrangement is bidirectionally regulated by D2Rs and is
extremely plastic in adult animals. For instance, increased collat-
erals in D2R-OE mice disappear 2 weeks after restoring D2R
expression to normal levels and then reappear after reinstating
D2R overexpression (by switching the transgene off and then
on). Importantly, pharmacological blockade of D2R function in
the adult animal with chronic administration of haloperidol also
led to a decrease in direct pathway collaterals without affecting
the classical terminal fields of the direct and indirect pathways.
This demonstrates that chronic administration of antipsychotic
medication in adulthood leads to specific changes in neuronal
connectivity in the adult basal ganglia circuitry.
GABAergic neurons of the indirect pathway are known to
inhibit the GPe. In line with this, we found that optogenetic
activation of the indirect pathway in vivo inhibited GPe activity.
Surprisingly, we found that optogenetic activation of the direct
pathway also inhibited GPe neurons in vivo with the same
latency as activation of the indirect pathway. This inhibition
was significantly increased inD2R-OEmice that possess excess
bridging collaterals, suggesting that increased bridging collat-
erals could be responsible for the increase in inhibition viamono-
synaptic inhibition. The direct and the indirect pathways have
classically been thought about as two functionally opposing
pathways (Albin et al., 1989; Maia and Frank, 2011). This holds
true for motor behaviors and is consistent with optogenetic
studies showing that direct pathway stimulation produces loco-
motor activation whereas indirect pathway stimulation inhibits
locomotion (Kravitz et al., 2010). The opposing function of both
pathways is also discussed in the context of motivation and
cognition, with the direct pathway being involved in learning
from positive outcomes and the indirect pathway in learning
from negative outcomes (Durieux et al., 2009; Ferguson et al.,
2011; Frank et al., 2004; Graybiel, 2000; Hikida et al., 2010;
Kravitz et al., 2010, 2012; Tai et al., 2012). Other models propose
coordinated activation of both pathways that could be simulta-neous or sequential in nature (Hikosaka et al., 2000; Mink,
2003; Nambu, 2008) or could rather involve the direct and the
hyperdirect pathway (Leblois et al., 2006). Coordinated activa-
tion of direct and indirect pathways in motor control is supported
by a recent study using in vivo calcium imaging showing that
both pathways are coactivated during locomotor initiation (Cui
et al., 2013). The density of bridging collaterals could be the
mean to regulate the coordinated actions of both pathways.
The fact that the observed anatomical changes are selective
for the bridging collaterals of the direct pathway and that the
behavioral activation of the direct—but not indirect—pathway
is disrupted implies a functional role of these collaterals in
regulating striatal-dependent behaviors. Our in vivo recordings
suggest that bridging collaterals may form a functional bridge
between the direct and the indirect pathways, hence acting as
a concurrent ‘‘brake’’ when the ‘‘accelerator’’ (direct) pathway
is activated (Graybiel, 2000). To test this idea, we used the
open field experiment designed by Kravitz et al. (2010) as a
readout for direct and indirect pathway strength. In both mouse
models with increased bridging collaterals (AAV-Kir2.1AAA and
D2R-OE mice), behavioral activation of the direct pathway was
disrupted, in line with the observation of the selective anatomical
changes in the direct pathway. In fact, direct pathway stimulation
leads to decreased locomotor activity in Kir2.1AAA and D2R-OE
mice, while wild-type mice show increased locomotor activity.
Strikingly, this decrease is reversed by chronic pharmacological
blockade of D2Rs, emphasizing the importance of D2R function
in this plasticity.
The decrease in locomotor activity after direct pathway activa-
tion in Kir2.1AAA and D2R-OE mice may be explained by the
increased inhibition of GPe neurons, therefore reinforcing the
‘‘brake’’ action of the indirect pathway. In contrast, retracting
collaterals should weaken the indirect pathway. Following this
idea, we expected that haloperidol-treated mice that have less
bridging collaterals would show facilitated locomotor activity
after direct pathway stimulation due to decreased opposition
by collateral input to the GPe. We did not observe this, possibly
due to a ceiling effect of optogenetic stimulation.
Although the behavioral data are consistent with increased
inhibition byGPe collaterals, it is possible that other mechanisms
are contributing to the behavioral inhibition after direct pathway
stimulation. For example, increased D2R expression and
increased striatal excitability may have led to reversible changes
within the striatum that do not allow optimal activation of the
direct pathway, thereby impairing the efficacy of the striatonigral
synapse. Moreover, functional connectivity within the basal can
also be due to plasticity in striatal input. In line with this hypoth-
esis, altered activity within the striatum during postnatal devel-
opment has been shown to regulate the strength of excitatory
input to the striatum (Kozorovitskiy et al., 2012).
The direct and indirect pathways are important not only for
regulating motor activity but also for motivational and cognitive
behaviors (Maia and Frank, 2011). Regulating the extent of
bridging collaterals therefore might be important not only for
refining locomotion but also for regulating cognitive and motiva-
tional behaviors. For instance, D2R-OE mice show deficits
in motivation and cognition that resemble negative and cognitive
symptoms observed in patients with schizophrenia (Bach et al.,Neuron 81, 153–164, January 8, 2014 ª2014 Elsevier Inc. 161
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2012; Ward et al., 2012). Both the deficits in motivation and the
anatomical changes are reversed after reversing D2R levels to
normality in adulthood. It is therefore possible that the changes
in bridging collaterals are responsible for the motivational defi-
cits. In contrast, the cognitive deficits persist after reversing
D2R overexpression, suggesting that the anatomical changes
are not sufficient to explain the cognitive deficits (Bach et al.,
2008; Kellendonk et al., 2006). To address causality between
bridging collaterals and motivation, the collaterals will have to
be manipulated directly without affecting neuronal excitability
or D2R function. Anatomical changes in the bridging collaterals
may also contribute to basal ganglia disorders such as Parkin-
son’s disease, in which an imbalance of the direct and indirect
pathways has been postulated (Albin et al., 1989; Maia and
Frank, 2011). In this context, it would be interesting to examine
bridging collaterals in mouse models of Parkinson’s disease.
Finally, there is evidence for increased D2R stimulation in the
striatum (associative caudate) of patients with schizophrenia
(Howes et al., 2012; Kegeles et al., 2010; Simpson et al., 2010).
D2R-OE mice were originally designed to model this aspect of
the disorder (Kellendonk et al., 2006). We therefore hypothesize
that increased bridging terminals and the resulting changes in
the balance of the direct and indirect pathways might also exist
in patients with schizophrenia. Advanced brain-imaging technol-
ogies capable of identifying changes at the level of terminal fields
might be used in the future to test this hypothesis. In this context,
it is interesting that chronic treatment with haloperidol, a widely
used antipsychotic medication to treat patients with schizo-
phrenia, reverses both the anatomical alteration and the disrup-
ted behavioral consequence of direct pathway stimulation in
D2R-OEmice. The longitudinal study following the same animals
before and after treatment strongly suggests that haloperidol
corrects the direct-pathway-dependent behavioral deficits by
reversing the increase in collaterals. Because all effective phar-
macotherapies for positive symptoms of schizophrenia target
D2Rs, we propose here that these medications possibly atten-
uate positive symptoms by correcting an anatomical imbalance
between the direct and indirect pathways.EXPERIMENTAL PROCEDURES
Animals
All animal protocols used in the present study were approved by the New York
State Psychiatric Institute and Columbia University Institutional Animal Care
and Use Committees. The generation of theD2R-OEmice has been described
previously (Kellendonk et al., 2006). TetO-D2R mice have been backcrossed
for over 15 generations onto the C57BL/6J background and CaMKIIa-tTA
mice backcrossed for over 20 generations onto 129SveVTac. To generate
D2R-OE mice, tetO-D2R/C57BL6 mice were crossed with CaMKIIa-tTA/
129SveV mice. Only double transgenic mice express transgenic D2Rs (D2R-
OEmice). Littermates carrying a single transgene (tetO or tTA) or no transgene
were used as controls. Drd2-GFP (S118Gsat/Mmnc), Drd1a-GFP (X60Gsat/
Mmmh), Drd2-CRE (ER44Gsat/Mmcd), and Drd1a-CRE (FK150Gsat/Mmcd)
mice were purchased from MMRRC, and Drd2/ (B6.129S2-Drd2tm1Low/J)
were purchased from Jackson Laboratory. These strains were crossed to
obtainD2R-OE;Drd1a-GFP,D2R-OE;Drd2-GFP,Drd2/;Drd1a-GFP,Drd2+/;
Drd1a-GFP, Drd2+/;Drd2-GFP, Drd1a-GFP;Drd1a-CRE, and Drd1a-
GFP;Drd2-CRE mice. All controls were littermates. Only adult mice were
used in this study. For unknown reasons, no Drd2/;Drd2-GFP mice could162 Neuron 81, 153–164, January 8, 2014 ª2014 Elsevier Inc.be obtained. Mice were housed under a 12 hr light/dark cycle in a tempera-
ture-controlled environment with food and water available ad libitum.
Drug Treatments
Expression of transgenic D2R inD2R-OEmice was switched off by feeding the
mice with regular chows supplemented with doxycycline (40 mg/kg diet). Re-
expression of transgenic D2R was allowed by replacing doxycycline-supple-
mented food with regular pellets for 60 days. Re-expression of transgenic
D2R was assessed by in situ hybridization (Kellendonk et al., 2006).
Chronic treatment with haloperidol (1mg/kg/day) was performed usingmini-
osmotic pumps (Alzet, model 2002) to provide a steady delivery rate of 0.5 ml/hr
for 14 days. Haloperidol was dissolved in 8.5% lactic acid (six parts) then
neutralized with 1N NaOH (four parts). Minipumps filled with either lactic
acid/NaOH or haloperidol were implanted subcutaneously in the interscapular
region under isoflurane anesthesia.
Histology and Quantification of Terminal Field Density
Terminal quantification was estimated by immunohistochemistry against
aequorea GFP expressed in Drd1a-GFP and Drd2-GFP mice. Mice were
anaesthetized with a mixture of ketamine and xylazine (100 mg/kg and
10 mg/kg) injected intraperitoneally (i.p.) and transcardiacally perfused with
first PBS and then 4% paraformaldehyde. Following perfusion, brains were
postfixed in 4% paraformaldehyde for 16 hr, extensively washed, and sliced
into 50 mm sagittal sections on a vibratome (Leica Microsystems). Immuno-
staining was performed on free-floating sections from either right or left
hemisphere. Every fourth section covering GPe and SNr in their entirety
(approximately six slices per mouse) was stained using a rabbit polyclonal
antibody against aequorea GFP (1:2,000; Molecular Probes). The signal was
revealed using a biotinylated anti-rabbit (1:1,000; Jackson ImmunoResearch)
Vectastain ABC Elite kit (Vector Labs) and 3,30 diaminobenzidine (Vector
Labs). Contrast was intensified using 0.025% nickel cobalt and 0.02% nickel
ammonium sulfate. Sections were dehydrated, cleared, and mounted on
slides with Permount (Fisher Scientific). Brightfield and darkfield photomicro-
graphs were taken using an AxioImager 2 microscope (Zeiss) connected to an
AxioCam video camera and to Neurolucida v.10 (MBF Bioscience). Terminal
density was evaluated using GFP staining. Quantification was performed
using ImageJ v.1.46r by experimenters blind of genotypes/injections using
two random counting frames per structure and per slice. Optical density in
the striatum was not affected by genotype or Kir channel expression and
was used as an internal control, so all values are in percentage of striatal
optical density. All effects were cross-examined and validated using dark field
microscopy (Zeiss) at a higher magnification (103 and 403) and in some
occurrences using synaptophysin quantification (mouse monoclonal anti-syn-
aptophysin, 1:100; Abcam).
Note that antibodies directed against aequorea GFP expressed in Drd1a-
GFP and Drd2-GFP mice do not recognize renilla GFP expressed by AAV-
ires-HRGFP.
Immunofluorescence was performed on free-floating, 50-mm-thick sections
using rabbit anti-aequorea GFP (1:2,000; Molecular Probes), chicken anti-
aequorea GFP (1:1,000; Abcam), rabbit anti-DsRed (1:1,000; Clontech), rabbit
anti-CRE (1:1,000; Kellendonk et al., 1999), mouse anti-PV (1:2,000; Sigma),
and the appropriate fluorescent-labeled secondary antibodies. Sections
were mounted on slides with VectaShield+DAPI (Vector Labs). Images were
acquired using an AxioImager fluorescence microscope (Zeiss) or an LSM
510 META confocal system (Zeiss) mounted on an inverted Axiovert 200M
microscope (Zeiss) at the Herbert Irving Comprehensive Cancer Center
confocal facility (Columbia University).
Virus Constructs
AAV2/1-cmv-Kir2.1AAA-ires-HRGFP and AAV2/1-cmv-Kir2.1WT-ires-HRGFP
viruses were generated by inserting mouse Kir2.1AAA or Kir2.1WT sequences,
respectively, into the multiple cloning site of the pAAV-ires-HRGFP vector
(Agilent Technologies) as described in Cazorla et al. (2012). AAV2/1-syn-
DIO-Kir2.1AAA-ires-mCherry was generated by replacing the ef1a promoter
and ChR2-eYFP sequence with the synapsin promoter and Kir2.1AAA-ires-
mCherry sequence into the pAAV-ef1a-DIO-hChR2(H134R)-eYFP vector
(kind gift of Karl Deisseroth).
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cmv-Kir2.1WT-ires-HRGFP (1 3 1011 particles/ml) were produced at U Penn
Vector Core (University of Pennsylvania), AAV2/1-syn-DIO-Kir2.1AAA-ires-
mCherry (1 3 1013 particles/ml) was produced at Vector Biolabs, AAV2/1-
cmv-HRGFP (3.75 3 1012 particles/ml) was obtained from Vector Biolabs,
and AAV2-ef1a-DIO-mCherry (1 3 1012 particles/ml) and AAV5-ef1a-DIO-
ChR2(H134R)-eYFP (4 3 1012 particles/ml) were obtained from UNC Vector
Core (University of North Carolina). DIO constructs allow gene expression
only in cells that express CRE recombinase.
Stereotaxic Injections and Fiberoptic Implantations
Mice were anaesthetized with a mixture of ketamine and xylazine (100 mg/kg
and 10 mg/kg) injected i.p. and placed into a stereotaxic apparatus equipped
with a temperature controller to regulate body temperature. Viruses were bilat-
erally delivered at an average rate of 100 nl/min using glass pipettes (10–
15 mm). Two sites of injections were used into the mediodorsal striatum to
allow for a broad expression (site A: anterior-posterior [AP] +1.3, medio-lateral
[ML] ±1.4, dorso-ventral [DV] 3.2; site B: AP +0.8, ML ±2.0, DV 3.4). A total
of 0.4–0.5 ml of AAV2/1-cmv-Kir2.1AAA-ires-HRGFP, AAV2/1-cmv-HRGFP,
AAV2/1-syn-DIO-Kir2.1AAA-ires-mCherry, and AAV2-ef1a-DIO-mCherry and
0.5–1.0 ml of AAV2/1-cmv-Kir2.1WT-ires-HRGFP (lower titer) were injected
per site. For double virus injections (AAV2/1-cmv-Kir2.1AAA-ires-HRGFP +
AAV5-ef1a-DIO-ChR2(H134R)-eYFP and AAV2/1-cmv-HRGFP + AAV5-ef1a-
DIO-ChR2(H134R)-eYFP), an equal volume of each virus wasmixed and a final
volume of 1.0–1.5 ml was injected per site. After each injection, the pipette re-
mained in situ for 10 min to minimize leaking. For tracing experiments, sparse
expression of ChR2 was obtained by injecting low titer of AAV5-ef1a-DIO-
ChR2(H134R)-eYFP (4 31012 particles/ml diluted 1:10 in autoclaved, filtered
PBS/5% glycerol; 0.44 ml) in the mediodorsal striatum (AP +1.0, ML ±1.4,
DV 3.1) of Drd1a-CRE;control and Drd1a-CRE;D2R-OE mice. Expression
of the virus was allowed for a period of 4 weeks.
For optical fibers implantation, the injection glass pipette was removed and
fiberoptic implants were placed in the dorsomedial striatum (AP +0.8, ML ±1.8,
DV3.2). The implant was secured to the skull using dental cement (Dentsply).
After wound closure, mice received analgesics and antibiotics and were re-
turned to their home cage for >4 weeks. Virus spreading and gene expression
were assessed after each experiment. Variability was very low and no mice
were removed from any experiment.
In Vivo Optical Stimulation
Optical fibers were constructed in house by interfacing a 200 mm, 0.37-numer-
ical-aperture optical fiber (Fiber Instrument Sales) with a 1.25 mm stick zirco-
nium ferrule. The fiber extended 4 mm beyond the end of the ferrule. Fibers
were attached with epoxy resin into the ferrules, then cut with a diamond
pen and polished. All fibers were calibrated to have >80% efficiency of light
transmission. Fiberoptic patch cords with a 200 mm core diameter were also
constructed in house using an FC/PC connectorization kit (Thor Labs).
In Vivo Recording
Anesthetized mice (chloral hydrate) were implanted with an optic fiber for light
stimulation into the site of ChR2 injection in the dorsomedial striatum (AP +1.5,
ML ±1.1, DV 3.3). A glass electrode (impedance 12–14 MU) filled with 2 M
NaCl was lowered into the GPe (AP 0.1, ML ±1.8, DV 2.5). The electrode
was lowered using a hydraulic microdrive to detect spontaneously active pal-
lidal neurons. From this starting point, the GPe was sampled in four locations
0.15 mm apart and arranged in a 2 3 2 spaced grid moving in a clockwise
direction. The starting locations were counterbalanced across animals and
groups. Pallidal neurons were identified using a combination of sterotaxic
position and narrow action potential width (<1 ms). After 2–3 min of stable
recording, optical stimulation (473 nm; 2 mW) was applied for 5 s as recording
continued. Neuronal activity was amplified and filtered (1,0003 gain, 100–
10K Hz band pass) and fed to an audio monitor and to a computer interface
with custom-designed acquisition and analysis software (Neuroscope).
Traces from continuous recordings were analyzed offline, first by applying a
window discriminator to identify spikes, then from the spike table to calculate
firing rates. Peri-stimulus time histograms were obtained by sampling spike
frequency with 100 ms bins 5 s before, during, and after laser illumination.Relative spike frequency is expressed as a function of baseline firing obtained
during the 5 s preceding laser illumination. Average firing rate during the 5 s of
laser stimulation was expressed as a percent change and a Z score of the
prestimulation firing rate distribution, which was determined from five 1 s
bins pseudorandomly sampled from the 60 s prior to stimulation. Cells with
Z scores more negative than 2 (cutoff for a one-tailed p < 0.05) were defined
as being significantly inhibited by striatal efferent stimulation. Proportion of
cells with significant changes in spike firing following laser stimulation and
amplitude of inhibition, calculated as (1 post-/prefiring rate) 3 100, were
also analyzed and compared.
Data Analysis and Statistics
Data were analyzed using Prism 5 (GraphPad) and Statview. Terminal field
density was analyzed using unpaired Student’s t test when only two conditions
were compared within a group (GPe or SNr) or one-way ANOVA followed by a
Bonferroni post hoc test when more than two conditions were compared
within a group. In vivo recordings were analyzed using a paired t test to
compare pre- to postfiring rate distribution, a Pearson’s chi-square test to
compare the proportion of inhibited units across different groups, and one-
way ANOVA followed by post hoc comparisons for the degree of inhibition
(expressed as both Z score and percentage change from prestimulation spike
firing). Motor activity was analyzed using two-way ANOVA with repeated mea-
sures. The p values of repeated ANOVAs are given for each type of activity.
Virus expression (AAV-ctl or AAV-Kir2.1AAA), genotypes (control or D2R-OE
mice), treatment (saline or haloperidol), and laser illumination are independent
variables. All statistical analyses were conducted with an alpha level of 0.05.
Data are presented as mean ± SEM unless otherwise stated. The n values
indicate the number of mice per group.
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